oxygen
Synthetic Blood International, Inc. (SYBD.OB) Receives Grants Exceeding $5 Million
Read the full article: http://blog.qualitystocks.net/?p=10731
The Department of Defense has awarded Synthetic Blood International a number of grants totaling more than $5.3 million. The funding from these grants will be used to study clinical applications for Oxycyte®, company’s perfluorocarbon therapeutic oxygen carrier.
Vested Interest:
The author does not own shares in SYBD- Login or register to post comments
- Email this page
Related Articles
- Synthetic Blood International, Inc. (SYBD.OB) Receives Grants Exceeding $5 Million
- ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Announces Research Agreement with George Mason University
- AVANIR Pharmaceuticals (AVNR) Receives European Patent Approval for Extended Commercial Exclusivity for Zenair
- Chembio Diagnostics, Inc. (CEMI.OB) Reports Strong Third Quarter Results
- Medical Connections Holdings, Inc. (MCTH.OB) Reports 58% Revenue Increase